Headaches, including migraines, are common. It is estimated that one out of every six Americans experiences migraines or severe headaches. Over-the-counter (OTC) medications for migraines are ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

The global Over-the-Counter (OTC) drugs market is poised for significant growth, with expectations to expand from a valuation of USD 151.15 billion in 2023 to USD 213.08 billion by 2030.

(HealthDay News) — Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according to a ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

Nasdaq Delisting and Subsequent Initiation of Trading on OTC Pink Sheets. On October 4, 2024 ... receptor modulator being developed as a potential treatment for acute and chronic neuropathic pain ...

Opioids can have profound effects when not taken as prescribed. Your healthcare provider will work with you to determine the best medication for your pain. This article explores what opioid medication ...

For a list of products with lower levels of benzene as well as alternatives for managing skin blemishes, you may wish to read our “eGuide to Acne Solutions.” This online resource may be found under ...

Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.